BACKGROUND: Intense liver uptake of (99m)Tc-sestamibi (MIBI) often interferes with visualization of myocardial perfusion in the inferior wall of the left ventricle. To develop improved myocardial perfusion agents, crown ether-containing dithiocarbamates and bisphosphines have been introduced in recent years. This study was designed to investigate the myocardial imaging properties and in vivo kinetics of a cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, in comparison with MIBI. METHODS: Dynamic cardiac images were acquired for 60 minutes after intravenous tracer injection using a small-animal SPECT system in healthy control rats and rats with myocardial infarcts. Myocardial and liver time-activity curves were generated for radiopharmaceutical kinetic analysis. RESULTS: Good visualization of the left ventricular wall and perfusion defects could be achieved 20 minutes after (99m)Tc-15C5-PNP administration. (99m)Tc-15C5-PNP images in all hearts with infarcts showed perfusion defects, which were comparable to MIBI images. The kinetic curves plotted from 1 to 60 minutes demonstrated that (99m)Tc-15C5-PNP has a shorter washout half-life (6.4 ± 3.2 vs 124 ± 30.5 minutes, P < .01) in the liver, lower residual liver activity (14.5 ± 10.2% vs 36.5 ± 28.9%, P < .01), and higher heart/liver ratio than MIBI. CONCLUSIONS: (99m)Tc-15C5-PNP has potential for rapid myocardial perfusion imaging with low liver uptake.
BACKGROUND: Intense liver uptake of (99m)Tc-sestamibi (MIBI) often interferes with visualization of myocardial perfusion in the inferior wall of the left ventricle. To develop improved myocardial perfusion agents, crown ether-containing dithiocarbamates and bisphosphines have been introduced in recent years. This study was designed to investigate the myocardial imaging properties and in vivo kinetics of a cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, in comparison with MIBI. METHODS: Dynamic cardiac images were acquired for 60 minutes after intravenous tracer injection using a small-animal SPECT system in healthy control rats and rats with myocardial infarcts. Myocardial and liver time-activity curves were generated for radiopharmaceutical kinetic analysis. RESULTS: Good visualization of the left ventricular wall and perfusion defects could be achieved 20 minutes after (99m)Tc-15C5-PNP administration. (99m)Tc-15C5-PNP images in all hearts with infarcts showed perfusion defects, which were comparable to MIBI images. The kinetic curves plotted from 1 to 60 minutes demonstrated that (99m)Tc-15C5-PNP has a shorter washout half-life (6.4 ± 3.2 vs 124 ± 30.5 minutes, P < .01) in the liver, lower residual liver activity (14.5 ± 10.2% vs 36.5 ± 28.9%, P < .01), and higher heart/liver ratio than MIBI. CONCLUSIONS: (99m)Tc-15C5-PNP has potential for rapid myocardial perfusion imaging with low liver uptake.
Authors: Shiou-Chi Cherng; Yeong H Chen; Meei S Lee; Shih P Yang; Wen S Huang; Cheng Y Cheng Journal: Nucl Med Commun Date: 2006-11 Impact factor: 1.690
Authors: Zhonglin Liu; George A Kastis; Gail D Stevenson; Harrison H Barrett; Lars R Furenlid; Matthew A Kupinski; Dennis D Patton; Donald W Wilson Journal: J Nucl Med Date: 2002-07 Impact factor: 10.057
Authors: A Boschi; C Bolzati; L Uccelli; A Duatti; E Benini; F Refosco; F Tisato; A Piffanelli Journal: Nucl Med Commun Date: 2002-07 Impact factor: 1.690
Authors: Leonie Wyffels; Brian D Gray; Christy Barber; Stephen K Moore; James M Woolfenden; Koon Y Pak; Zhonglin Liu Journal: Bioorg Med Chem Date: 2011-04-28 Impact factor: 3.641
Authors: Fangyuan Zhao; Christy J Barber; Saad Sammani; Li Wan; Brian W Miller; Lars R Furenlid; Zheng Li; Deepa B Gotur; Roberto Barrios; James M Woolfenden; Diego R Martin; Zhonglin Liu Journal: Nucl Med Biol Date: 2022-10-14 Impact factor: 2.947